NCT00817050

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)

A Preference Evaluation of Nasonex® Nasal Spray (Unscented) vs. Flonase® Nasal Spray (Scented) in Subjects With Symptomatic Allergic Rhinitis (AR) - Single-Dose Cross-over

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This was a one-day single dose trial conducted to compare patient's preference for Nasonex® (mometasone) versus Flonase® nasal spray. Each patient was randomized to take one dose (2 sprays in each nostril) of Nasonex or Flonase. Thirty minutes later, each patient was to take one dose of the opposite medication. Questionnaires were given to each patient after each drug dose to evaluate patient product preference.

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Mometasone Furoate Nasal Spray	One dose (2 sprays in each nostril) of Mometasone Furoate Nasal Spray
DRUG	fluticasone nasal spray	One dose (2 sprays in each nostril) of fluticasone nasal spray

Timeline

• Start date: 2004-12-01
• Primary completion: 2005-01-01
• Completion: 2005-01-01
• First posted: 2009-01-06
• Last updated: 2024-08-15